1. PRMT4 inhibitor TP-064 impacts both inflammatory and metabolic processes without changing the susceptibility for early atherosclerotic lesions in male apolipoprotein E knockout mice. (December 2021) Authors: Zhang, Yiheng; Verwilligen, Robin A.F.; de Boer, Miriam; Sijsenaar, Timothy J.P.; Van Eck, Miranda; Hoekstra, Menno Journal: Atherosclerosis Issue: Volume 338(2021) Page Start: 23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗